CCL2 and metabolic dysfunction-associated steatohepatitis: In NASH, the role of MCP-1 is controversial; MCP-1 deficiency in mice fed a methionine choline deficient diet didn’t affect the development of steatohepatitis, but actually decreased fibrosis [21], and didn’t impact liver disease progression [51].